WORLD'S LARGEST MARKET RESEARCH RESOURCE — 1,519,265 REPORTS

 
 
• SEARCH FOR A REPORT

Viewing report

Search
Enter keywords, a title or a report id number below.
Advanced

• ORDER BY FAX

Order By Fax

• SELECT SITE CURRENCY

Select a currency for use throughout the site



  • Electronic (PDF) Information Icon
  • Site License Information Icon
  • Enterprisewide Information Icon
Live Chat Live Help Software for Website

IDEXX Laboratories, Inc. (IDXX) - Financial and Strategic SWOT Analysis Review

GlobalData, April 2011, Pages: 46

IDEXX Laboratories, Inc. (IDXX) - Financial and Strategic SWOT Analysis Review

Summary

IDEXX Laboratories, Inc. (IDEXX) is a diagnostics company engaged in the development, manufacture and distribution of products and services for the veterinary, dairy and water testing markets. It also distributes portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostic industry. Further, the company provides diagnostics for detection of microbiological contamination of drinking water, and for screening of antibiotic residues in milk. The company operates and markets its products in four segments, namely, Companion Animal Group (CAG), Water, Livestock and Poultry Diagnostics (LPD) and Other (Dairy, OPTI Medical). The company has its research and development facilities in the US, the UK and Canada. It offers services in about 140 countries across the world. IDEXX is headquartered in Maine, the US.

IDEXX Laboratories, Inc. Key Recent Developments…

Jan 28, 2011: IDEXX Laboratories Reports Net Income Of $36.4 Million For Q4 2010
Oct 22, 2010: IDEXX Laboratories Reports Net Income Of $34.71 Million In Q3 2010
Jul 23, 2010: IDEXX Laboratories Reports Net Income Of $37.19 Million In Q2 2010
Apr 23, 2010: IDEXX Laboratories Reports Net Income Of $33 Million In Q1 2010
Apr 06, 2010: IDEXX Laboratories To Invest $50 Million Into Maine Facility

This comprehensive SWOT profile of IDEXX Laboratories, Inc. provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.



List of Tables
List of Figures
Section 1 - About the Company
IDEXX Laboratories, Inc. - Key Facts
IDEXX Laboratories, Inc. - Key Employees
IDEXX Laboratories, Inc. - Key Employee Biographies
IDEXX Laboratories, Inc. - Major Products and Services
IDEXX Laboratories, Inc. - History
IDEXX Laboratories, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
IDEXX Laboratories, Inc. - Key Manufacturing Facilities
Section 2 – Company Analysis
IDEXX Laboratories, Inc. - Business Description
Business Description - CAG
CAG - Overview
CAG - Financials
Business Description - LPD
LPD - Overview
LPD - Financials
Business Description - Other
Other - Overview
Other - Financials
Business Description - Water
Water - Overview
Water - Financials
IDEXX Laboratories, Inc. - Corporate Strategy
IDEXX Laboratories, Inc. - SWOT Analysis
SWOT Analysis - Overview
IDEXX Laboratories, Inc. - Strengths
Strength - Constant Growth in Revenues
Strength - Strong Cash Reserves
Strength - Broad Product Portfolio
Strength - Diversified Geographic Presence
IDEXX Laboratories, Inc. - Weaknesses
Weakness - Bargaining Power of Suppliers
IDEXX Laboratories, Inc. - Opportunities
Opportunity - Market Growth in Emerging Economies
Opportunity - Perpetual Innovation
Opportunity - Potential Market: POC
Opportunity - Changing Demographics
IDEXX Laboratories, Inc. - Threats
Threat - Changing Diagnostic Market Conditions
Threat - Stringent Government Regulations
Threat - Distributor Purchasing Patterns
Threat - Highly Competitive Environment
IDEXX Laboratories, Inc. - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
IDEXX Laboratories, Inc., Medical Equipment, Deals By Year, 2005 to YTD 2011
IDEXX Laboratories, Inc., Medical Equipment, Deals By Type, 2005 to YTD 2011
IDEXX Laboratories, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2005 to YTD 2011
IDEXX Laboratories, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2005 to YTD 2011
IDEXX Laboratories, Inc., Recent Deals Summary
Section 5 – Company’s Recent Developments
Jan 28, 2011: IDEXX Laboratories Reports Net Income Of $36.4 Million For Q4 2010
Oct 22, 2010: IDEXX Laboratories Reports Net Income Of $34.71 Million In Q3 2010
Jul 23, 2010: IDEXX Laboratories Reports Net Income Of $37.19 Million In Q2 2010
Apr 23, 2010: IDEXX Laboratories Reports Net Income Of $33 Million In Q1 2010
Apr 06, 2010: IDEXX Laboratories To Invest $50 Million Into Maine Facility
Mar 02, 2010: IDEXX Laboratories Elects Joseph Vumbacco As Director
Jan 29, 2010: IDEXX Laboratories Reports Net Income Of $122.2 Million In 2009
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Antech Diagnostics
Abbott Diagnostics
Siemens Healthcare
VCA Antech, Inc.
Radiometer A/S
Roche Diagnostics Limited
Neogen Corporation
Instrumentation Laboratory
Abaxis, Inc.

Customers who bought this item also bought